---
title: "Weekly Recap | BTSG.US +5.79%, outperforming the S&P 500"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301465332.md"
description: "BrightSpring Health Services (BTSG) gained 5.79% this week to close at $63.74, while the S&P 500 rose 1.15%, leaving the stock about 4.64 percentage points ahead of the benchmark. The week began with a bounce on Monday (5 October) from the $60.05 area to $62.00, followed by a push to a weekly high of $65.64 on Tuesday (6 October) before settling at $63.75. The next three sessions held within a $62.62–$65.09 range, closing Friday (9 October) at $63.74."
datetime: "2026-10-10T06:14:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301465332.md)
  - [en](https://longbridge.com/en/news/301465332.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301465332.md)
generator: "portal-rs"
---

# Weekly Recap | BTSG.US +5.79%, outperforming the S&P 500

## The Week

BrightSpring Health Services (BTSG) gained 5.79% this week to close at $63.74, while the S&P 500 rose 1.15%, leaving the stock about 4.64 percentage points ahead of the benchmark. The week began with a bounce on Monday (5 October) from the $60.05 area to $62.00, followed by a push to a weekly high of $65.64 on Tuesday (6 October) before settling at $63.75. The next three sessions held within a $62.62–$65.09 range, closing Friday (9 October) at $63.74. There was no major catalyst during the week; volume ran modestly above the 60-day median.

## Analyst Ratings

As of 7 October 2026, 18 brokers cover the stock: 15 rate it buy and 3 rate it overweight, with no hold, underweight, or sell ratings. The consensus rating is strong buy, and the consensus target sits at $78.94, about 23.85% above the latest price. Target prices range from $70 to $90, a gap of roughly $20 that points to some divergence on the upside. Within its medical services industry group of 53 names, BTSG ranks 6th by rating.

## The Week Ahead

On Tuesday (13 October), the US releases the NFIB small business optimism index and existing home sales; on Wednesday (14 October), CPI and core CPI prints land, and these macro figures may shape risk appetite across healthcare services. On the company side, BrightSpring’s third-quarter fiscal 2026 results are due on 30 October before the open, with consensus estimates at $0.41 EPS and $3.868 billion in revenue. Attention will gradually shift to that update after the coming week.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [BTSG.US](https://longbridge.com/en/quote/BTSG.US.md)

## Related News & Research

- [Cantor Fitzgerald Investment Advisors L.P. Makes New $1.74 Million Investment in BrightSpring Health Services, Inc. $BTSG](https://longbridge.com/en/news/302839274.md)
- [Throwback to Nebius stock losing a third after Meta's AI cloud move](https://longbridge.com/en/news/302964390.md)
- [Sterling Capital Management LLC Buys 4,223 Shares of Cigna Group $CI](https://longbridge.com/en/news/302966951.md)
- [Amazon.com, Inc. $AMZN Stock Sold by Cohen Klingenstein LLC](https://longbridge.com/en/news/302980467.md)
- [Alphabet Inc. $GOOG Stock Sold by Axxcess Wealth Management LLC](https://longbridge.com/en/news/302979783.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**